Longitude Capital Partners III LLC 13D and 13G filings for Talaris Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-10-30 5:16 pm Sale | 2023-10-19 | 13D | Talaris Therapeutics, Inc. TALS | Longitude Capital Partners III LLC | 322,077 1.600% | -1 (-0.00%) | Filing |
| 2021-05-21 4:28 pm Purchase | 2021-05-11 | 13D | Talaris Therapeutics, Inc. TALS | Longitude Capital Partners III LLC | 322,078 7.800% | 322,078 (New Position) | Filing |